Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents-Reference-Cited by-同舟云学术

Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents

Published:2014-04-06 Issue:8 Volume:93 Page:1391-1400
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Ferrero Dario,Crisà Elena,Marmont Filippo,Audisio Ernesta,Frairia Chiara,Giai Valentina,Gatti Tiziana,Festuccia Moreno,Bruno Benedetto,Riera Ludovica,Passera Roberto,Boccadoro Mario

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2047-7.pdf

Reference49 articles.

1. Appelbaum FR, Gundacker H, Head DR et al (2006) Age and acute myeloid leukemia. Blood 107:3481–3485

2. Büchner T, Berdel WE, Haferlach C et al (2009) Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol 27:61–69

3. Juliusson G, Antunovic P, Derolf A et al (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 113:4179–4187

4. Bello C, Yu D, Komrokji RS et al (2011) Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome. Cancer 117:1463–1469

5. Ruutu T, Hänninen A, Järventie G et al (1997) Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine. Leuk Res 21:133–138

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple small‐dose infusions of G‐CSF‐mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia;British Journal of Haematology;2024-07-07

2. Antiproliferative and immunoregulatory actions of vitamin D derivatives on hematological malignancies;Feldman and Pike's Vitamin D;2024

3. Consenso de leucemia mieloide aguda en México;Gaceta Médica de México;2023-03-28

4. Prophylactic treatment of postallograft relapse in acute myeloid leukaemia;HEMATOLOGIE;2023

5. Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial;Leukemia Research;2021-12